Ironwood Pharmaceuticals, Inc.
Modified or Targeted Release Formulations of Linaclotide
Last updated:
Abstract:
The present invention relates to delayed release pharmaceutical compositions comprising linaclotide or pharmaceutically acceptable salts thereof, as well as to various methods and processes for the preparation and use of the compositions.
Status:
Application
Type:
Utility
Filling date:
11 Mar 2022
Issue date:
30 Jun 2022